Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP540435.RAwO2gC9S-pYwMV2pktWDfjBYGG2vKV5m8AHWlZGEFPMw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP540435.RAwO2gC9S-pYwMV2pktWDfjBYGG2vKV5m8AHWlZGEFPMw130_assertion type Assertion NP540435.RAwO2gC9S-pYwMV2pktWDfjBYGG2vKV5m8AHWlZGEFPMw130_head.
- NP540435.RAwO2gC9S-pYwMV2pktWDfjBYGG2vKV5m8AHWlZGEFPMw130_assertion description "[Small interfering RNA (siRNA) inhibition established that organization of invadopodia structure requires cortactin, whereas protease inhibitor studies identified membrane type 1 matrix metalloproteinase (MT1-MMP) as the key invadopodial enzyme responsible for gelatin matrix degradation in the breast carcinoma cell line MDA-MB-231.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP540435.RAwO2gC9S-pYwMV2pktWDfjBYGG2vKV5m8AHWlZGEFPMw130_provenance.
- NP540435.RAwO2gC9S-pYwMV2pktWDfjBYGG2vKV5m8AHWlZGEFPMw130_assertion evidence source_evidence_literature NP540435.RAwO2gC9S-pYwMV2pktWDfjBYGG2vKV5m8AHWlZGEFPMw130_provenance.
- NP540435.RAwO2gC9S-pYwMV2pktWDfjBYGG2vKV5m8AHWlZGEFPMw130_assertion SIO_000772 16540652 NP540435.RAwO2gC9S-pYwMV2pktWDfjBYGG2vKV5m8AHWlZGEFPMw130_provenance.
- NP540435.RAwO2gC9S-pYwMV2pktWDfjBYGG2vKV5m8AHWlZGEFPMw130_assertion wasDerivedFrom befree-2016 NP540435.RAwO2gC9S-pYwMV2pktWDfjBYGG2vKV5m8AHWlZGEFPMw130_provenance.
- NP540435.RAwO2gC9S-pYwMV2pktWDfjBYGG2vKV5m8AHWlZGEFPMw130_assertion wasGeneratedBy ECO_0000203 NP540435.RAwO2gC9S-pYwMV2pktWDfjBYGG2vKV5m8AHWlZGEFPMw130_provenance.